News headlines about LifePoint Health (NASDAQ:LPNT) have been trending positive this week, according to Accern. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. LifePoint Health earned a daily sentiment score of 0.42 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.2425012349868 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Shares of LPNT opened at $49.65 on Friday. LifePoint Health has a 1 year low of $41.45 and a 1 year high of $67.95. The company has a quick ratio of 1.49, a current ratio of 1.70 and a debt-to-equity ratio of 1.26. The company has a market capitalization of $1,950.83, a PE ratio of 13.68, a P/E/G ratio of 1.52 and a beta of 0.50.
LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.04). LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the previous year, the company posted $1.07 earnings per share. The company’s quarterly revenue was down 7.2% on a year-over-year basis. equities research analysts expect that LifePoint Health will post 4.23 earnings per share for the current year.
Several analysts recently weighed in on LPNT shares. ValuEngine downgraded LifePoint Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Goldman Sachs initiated coverage on LifePoint Health in a report on Wednesday, January 3rd. They issued a “sell” rating and a $45.00 price target for the company. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a report on Thursday, January 11th. Zacks Investment Research raised LifePoint Health from a “strong sell” rating to a “hold” rating in a report on Monday, January 22nd. Finally, Wells Fargo initiated coverage on LifePoint Health in a report on Tuesday, January 30th. They issued a “market perform” rating and a $52.00 price target for the company. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and seven have given a buy rating to the company’s stock. LifePoint Health has a consensus rating of “Hold” and a consensus target price of $54.31.
In related news, Chairman William F. Carpenter III bought 21,368 shares of the company’s stock in a transaction dated Wednesday, February 28th. The stock was acquired at an average cost of $46.80 per share, with a total value of $1,000,022.40. Following the acquisition, the chairman now owns 482,668 shares in the company, valued at approximately $22,588,862.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 8.76% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.